Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapyEdit Porpaczy, Veronika Sexl, Emmanuelle Clappier et al.|Blood|2018Cited by 155
Expansion of <i><scp>BCR</scp>/<scp>ABL</scp>1</i><sup>+</sup> cells requires <scp>PAK</scp>2 but not <scp>PAK</scp>1Leo Edlinger, Andrea Hoelbl‐Kovacic, Angelika Berger‐Becvar et al.|British Journal of Haematology|2017Cited by 17
Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor SurveillanceEva Maria Putz, Andrea Hoelbl‐Kovacic, Maria A. Hoelzl et al.|Cancers|2014Cited by 16